Subcutaneous administration of Hepatitis B immunoglobulin: efficacy and adherence
Treatment with Hepatitis B immunoglobulin (HBIg) has greatly reduced the risk of Hepatitis B (HBV) recurrence after liver transplantation1,2 and, together with antiviral therapy, it is now is...